Skip to main content
Erschienen in:

01.06.2019 | Case report

Dexamethasone

Vitreous haemorrhage and blepharoptosis: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Errera M-H, et al. A Comparison of the Dexamethasone Implant (Ozurdex) and Inferior Fornix-Based Sub-Tenon Triamcinolone Acetonide for Treatment of Inflammatory Ocular Diseases. Ocular Immunology and Inflammation 27: 319-329, No. 2, 17 Feb 2019. Available from: URL: http://doi.org/10.1080/09273948.2018.1501492 - France Errera M-H, et al. A Comparison of the Dexamethasone Implant (Ozurdex) and Inferior Fornix-Based Sub-Tenon Triamcinolone Acetonide for Treatment of Inflammatory Ocular Diseases. Ocular Immunology and Inflammation 27: 319-329, No. 2, 17 Feb 2019. Available from: URL: http://​doi.​org/​10.​1080/​09273948.​2018.​1501492 - France
Metadaten
Titel
Dexamethasone
Vitreous haemorrhage and blepharoptosis: 2 case reports
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-63685-0